Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.

[1]  A. Hutcheon,et al.  Neoadjuvant Docetaxel in Locally Advanced Breast Cancer , 2004, Breast Cancer Research and Treatment.

[2]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[3]  Hong Zhao,et al.  Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. , 2003, World journal of gastroenterology.

[4]  François Tranquart,et al.  Radiosensitivity of Rat Mammary Tumors Correlates With Early Vessel Changes Assessed by Power Doppler Sonography , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  Meiyappan Solaiyappan,et al.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  H. Junkermann,et al.  Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy , 2003, European Radiology.

[7]  Robert C. Brasch,et al.  Macromolecular contrast agents for MR mammography: current status , 2003, European Radiology.

[8]  Ying Lu,et al.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. , 2002, AJR. American journal of roentgenology.

[9]  P. Hahnfeldt,et al.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. , 2002, Journal of the National Cancer Institute.

[10]  François Tranquart,et al.  In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours. , 2002, Ultrasound in medicine & biology.

[11]  H. Tsuda,et al.  Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas , 2002, Breast cancer.

[12]  A. Rieber,et al.  Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy , 2002, European Radiology.

[13]  J. Bryant,et al.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.

[14]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Kaiser,et al.  Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies , 2001, Journal of magnetic resonance imaging : JMRI.

[16]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[17]  S. Harms,et al.  Technical Report of the International Working Group on Breast MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[18]  G Brix,et al.  Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[19]  G Brix,et al.  Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging. , 1998, Radiology.

[20]  M V Knopp,et al.  Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  H Zeitler,et al.  MRI of breast cancer: influence of chemotherapy on sensitivity. , 1997, The British journal of radiology.

[22]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.